XIENCE Safety Differentiators
XIENCE: Still the gold standard for safety
XIENCE Stent Design: Low Stent Thrombosis Rates1-6
A universal aim in the industry is to minimize the incidence of stent thrombosis (ST). XIENCE can point to a consistent trend of low stent thrombosis rates, even among complex patient populations.1-6
XIENCE Low Stent Thrombosis Rates in Complex Patients1-6
The XIENCE coating technology is a key factor in minimizing stent thrombosis.
Protecting Patients from Stent Thrombosis
XIENCE VS. OTHER DRUG-ELUTING STENTS
At rates of 0.0% and 0.1%, XIENCE outperforms other drug-eluting stents (DES) for 30-day stent thrombosis rates in these studies:
- The Resolute All Comers trial was designed to be representative of everyday clinical practice.7
- The Platinum Plus trial examined the XIENCE and Promus Element stents.8
Protecting Complex Patients
XIENCE VS. BARE METAL STENTS
Compared to bare metal stents (BMS) in a meta-analysis of all-comer complex patients, XIENCE was shown to save lives.
Discover more about Xience
AP2944592-WBO Rev. C